Title:
25-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITY
Document Type and Number:
WIPO Patent Application WO/2021/204812
Kind Code:
A3
Abstract:
The present invention relates to the field of vitamin D insufficiency and deficiency, viz. too low blood levels of 25(OH)D, and to their prevention and treatment. It provides a vitamin D supplement which comprises (i) a combination of 25(OH)D3 and/or 25(OH)D2 and vitamin D2; or (ii) a combination of 25(OH)D3 and/or 25(OH)D2 and vitamin D3; or (iii) a combination of 25(OH)D3 and/or 25(OH)D2 and a combination of vitamin D2 and vitamin D3, for use in the treatment of and/or prophylaxis of vitamin D insufficiency or deficiency in obese persons, overweight persons having the tendency to get obese or persons having a history of malabsorption of vitamin D or persons with a genetic disposition to develop obesity. Also provided are corresponding compositions and dosage regimens comprising such vitamin D supplements as well as kits comprising such compositions. Furthermore, corresponding dosage regimens for daily administration and corresponding product package inserts are also provided. The invention also relates to corresponding methods of treatment.
Inventors:
MÜLLER PETER M (CH)
HOLICK MICHAEL F (US)
HOLICK MICHAEL F (US)
Application Number:
PCT/EP2021/058958
Publication Date:
March 17, 2022
Filing Date:
April 06, 2021
Export Citation:
Assignee:
CARBOGEN AMCIS B V (NL)
AAMANYA AG (CH)
AAMANYA AG (CH)
International Classes:
A61K31/592; A61K31/593; A61P3/02; A61P3/04
Domestic Patent References:
| WO2009047644A2 | 2009-04-16 | |||
| WO2008134512A1 | 2008-11-06 | |||
| WO2009124210A1 | 2009-10-08 | |||
| WO2009101132A1 | 2009-08-20 |
Foreign References:
| US20190298744A1 | 2019-10-03 |
Attorney, Agent or Firm:
VOSSIUS & PARTNER (NO. 31) (DE)
Download PDF: